Your session is about to expire
← Back to Search
Pacemaker
Aveir VR Leadless Pacemaker for Arrhythmia
N/A
Waitlist Available
Research Sponsored by Abbott Medical Devices
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
Study Summary
This trialwill test the safety and effectiveness of a pacemaker for those with a certain heart condition.
Eligible Conditions
- Arrhythmia
- Slow Heart Rate
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Complication-Free Rate
Pacing thresholds and R-wave amplitudes within the therapeutic range
Secondary outcome measures
Appropriate and proportional rate response during graded exercise testing
Survival Rate of Patients implanted with the Nanostim Leadless Pacemaker
Trial Design
1Treatment groups
Experimental Treatment
Group I: Aveir VR Leadless PacemakerExperimental Treatment1 Intervention
VVIR pacing
Find a Location
Who is running the clinical trial?
Abbott Medical DevicesLead Sponsor
638 Previous Clinical Trials
403,862 Total Patients Enrolled
18 Trials studying Arrhythmia
10,434 Patients Enrolled for Arrhythmia
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger